Somatostatin peptide inhibits the secretion of growth hormone and insulin. Purchase high-purity Somatostatin for metabolic, neuroendocrine, and cancer research.
CAT No: R1683
CAS No:51110-01-1
Synonyms/Alias:SOMATOSTATIN;51110-01-1;Somatostatin-14;SRIF;Somiaton;Stilamin;CCRIS 7071;Panhibin;EINECS 256-969-7;Somatotropin release-inhibiting factor;19,34-bis(4-aminobutyl)-31-(2-amino-2-oxoethyl)-37-[[2-(2-aminopropanoylamino)acetyl]amino]-13,25,28-tribenzyl-10,16-bis(1-hydroxyethyl)-7-(hydroxymethyl)-22-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24,27,30,33,36-undecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35-undecazacyclooctatriacontane-4-carboxylic acid;(D-Trp8,D-Cys14)-Somatostatin-14;Somatostatin (Human, Ovine, Porcine, Rat, Mouse);AY 24910;[D-Trp8]-SOMATOSTATIN;NCGC00181005-01;AGCKNFFWKTFTSC;SCHEMBL3046327;HOR-299;PSI-4023-V;PSI-4101-V;PSI-4023;HB3088;AKOS015896026;DB-051897;L000577;Ala-Gly-Cys-Lys-Asn-Phe-Phe-D-Trp-Lys-Thr-Phe-Thr-Ser-Cys;AGCKNFFWKTFTSC (modifications: Disulfide bridge between 3 - 14);19,34-bis(4-aminobutyl)-37-[2-(2-aminopropanamido)acetamido]-13,25,28-tribenzyl-31-(carbamoylmethyl)-10,16-bis(1-hydroxyethyl)-7-(hydroxymethyl)-22-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24,27,30,33,36-undecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35-undecaazacyclooctatriacontane-4-carboxylic acid;Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys * 2AcOH * 6H2O; Somatostatin SRIF, Somatostatin-14;Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys, Somatostatin SRIF, Somatostatin-14;Growth hormone release-inhibiting factor, SST, SMS, SMST, GHIH, H-Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys-OH, So;
3. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
4. High fat diet and GLP-1 drugs induce pancreatic injury in mice
5. Cationic cell-penetrating peptides are potent furin inhibitors
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.